Taiwan Presses For Speedy Development Of Enterovirus Vaccine
This article was originally published in PharmAsia News
A Taiwan health official said the country expects to begin human trials of vaccines to treat enterovirus 71 infections blamed for the deaths of seven children this year. The head of Taiwan's Centers for Disease Control said animal testing could begin early next year as the country steps up efforts to produce vaccine. Health officials already fear a major outbreak of enterovirus this year. The CDC said the vaccine development would be made the priority government biotech project and seeks the aid of the Taiwanese biotech industry and academia to speed development. (Click here for more
You may also be interested in...
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.
Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis
In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.